Introduction

Angina refers to episodes of ischaemic chest pain or discomfort that lasts for 10 minutes or less and is alleviated with rest.1

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Describe the symptoms of and differentiate between stable and unstable angina
  • Discuss management options of stable and unstable angina
  • Summarise the role of the pharmacist in the management of stable and unstable angina.

Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.1, 2.3, 3.1, 3.5

Episodes of angina can be classified as an acute coronary syndrome; ST elevated and non-ST elevated myocardial infarctions (STEMI and NSTEMI), and high-risk unstable angina has been discussed in a previous article (Myocardial infarction, Australian Pharmacist, September 2020). Stable angina is a chronic ischaemic condition, with periodic episodes of consistent symptom severity, duration and predictable triggers (e.g. physical exertion).1 In unstable angina, there is an increase in the severity or duration of symptoms, or presentation of new symptoms.1

The management of angina involves treating and preventing episodes of angina as well as secondary prevention of cardiovascular events. This includes pharmacotherapy, lifestyle changes and sometimes revascu

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.